wide
accept
vast
major
diseas
develop
interact
gene
environ
concept
form
basi
studi
pathogenesi
mani
diseas
includ
autoimmun
diseas
almost
categori
autoimmun
diseas
organ
specif
system
natur
although
individu
autoimmun
diseas
rel
rare
popul
investig
far
project
data
estim
approxim
north
american
affect
least
one
autoimmun
diseas
best
known
autoimmun
diseas
type
diabet
rheumatoid
arthriti
multipl
sclerosi
grave
diseas
hashimoto
thyroid
myasthenia
gravi
system
lupu
erythematosu
syndrom
scleroderma
autoimmun
liver
diseas
autoimmun
hepat
primari
scleros
cholang
primari
biliari
cirrhosi
pbc
observ
mani
autoimmun
diseas
may
affect
one
individu
led
concept
mosaic
autoimmun
studi
genet
epigenet
factor
link
autoimmun
focu
ongo
research
also
exact
signal
cascad
govern
perpetu
inflammatori
process
respons
tissu
destruct
poorli
understood
recent
year
genom
wide
associ
studi
gwa
identifi
numer
genediseas
associ
mani
includ
autoimmun
diseas
although
associ
connect
genet
suscept
genet
dosag
number
associ
gene
requir
diseas
develop
well
defin
although
gwa
instrument
unlock
pathogenet
start
point
exposur
environment
factor
also
like
contribut
actual
develop
diseas
work
genet
induct
autoimmun
diseas
exampl
smoke
indic
increas
risk
develop
ms
individu
epidemiolog
studi
use
toxicolog
microbiolog
biochem
immunolog
test
import
order
identifi
environment
agent
includ
infecti
organ
xenobiot
chemic
compound
heavi
metal
prosthes
dental
materi
radiat
vaccin
food
name
heavi
metal
vaccin
also
implic
pathogenesi
autoimmun
autoinflammatori
syndrom
induc
adjuv
asia
fact
siliconosi
gulf
war
syndrom
gw
macrophag
myofasci
syndrom
mmf
postvaccin
phenomena
link
past
exposur
adjuv
sinc
gwa
underlin
view
multipl
gene
need
induc
autoimmun
also
like
sever
environment
trigger
either
complement
substitut
provok
immun
mediat
process
lead
autoimmun
addit
effect
trigger
interact
suscept
gene
remain
poorli
defin
recent
year
concept
exposom
introduc
mean
collat
possibl
measur
effect
environment
factor
exposom
take
account
intern
extern
stimuli
associ
diseas
provid
potenti
quantifi
way
evalu
environment
factor
fig
review
examin
role
exposom
relat
major
exemplari
autoimmun
diseas
genet
environ
like
play
key
role
pathogenesi
role
infectom
infecti
compon
microbiom
exposom
take
part
directli
indirectli
develop
autoimmun
also
introduc
fig
exposom
measur
exposom
repres
total
environment
exposur
exogen
endogen
begin
concept
extend
throughout
live
differ
previou
epidemiolog
studi
larg
concentr
extern
environ
specif
air
water
soil
food
contrast
approach
limit
extern
trigger
studi
exposom
need
address
endogen
factor
directli
indirectli
relat
environ
endogen
sourc
includ
byproduct
inflamm
lipid
peroxid
well
oxid
stress
compon
may
act
nucleophil
electrophil
would
capabl
dna
protein
modif
inde
bacteri
alter
glycosyl
pattern
immunoglobulin
note
sever
studi
collat
exposur
may
provid
fingerprint
particular
diseas
would
like
complement
data
gwa
predomin
problem
examin
environment
exposur
difficulti
quantif
normalis
well
determin
exposur
sequenc
inform
requir
alter
induc
one
environment
agent
may
necessari
subsequ
exposur
effect
moreov
environment
exposur
within
popul
well
within
individu
greatli
vari
given
myriad
caus
possibl
one
individu
may
use
clinic
look
caus
within
individu
term
exposur
sequenc
exposur
hierarchi
exposur
event
genet
risk
factor
initi
provok
exposur
variou
stimuli
examin
individu
piec
may
compris
jigsaw
puzzl
loss
immunolog
toler
develop
autoimmun
diseas
progress
fig
exposom
infectom
via
microbiom
exposom
describ
environment
factor
expos
lifetim
exogen
endogen
infecti
noninfecti
environment
exposur
basic
subdivid
infecti
noninfecti
agent
concept
infectom
introduc
describ
part
exposom
refer
collect
individu
exposur
infecti
agent
particip
pathogenesi
autoimmun
diseas
infectom
consid
part
microbiom
collect
microbi
product
human
bodi
expos
given
time
clinic
diseas
complic
although
great
variabl
may
seen
patient
patient
overal
collat
welldefin
diseaserel
exposur
individu
may
provid
pictur
diseas
develop
patient
exposom
provid
potenti
platform
exposur
may
measur
suggest
byproduct
individu
dna
protein
modif
serv
biomark
potenti
measur
blood
bodi
fluid
patient
via
technolog
liquid
chromatographytandem
mass
spectrometri
lcmsm
dna
adduct
function
measur
antioxid
capac
breath
analysi
rappaport
suggest
two
method
exposom
may
measur
bottomup
method
measur
chemic
air
water
extern
environ
limit
take
account
actual
uptak
substanc
intern
environ
subject
altern
topdown
method
measur
biomark
patient
blood
howev
method
indic
potenti
sourc
toxic
like
complementari
method
conjunct
refin
questionnair
defin
exposom
individu
larger
popul
frequent
sampl
could
demonstr
chang
marker
time
especi
critic
phase
develop
diseas
studi
pleil
colleagu
indic
breath
analysi
particular
biomark
capabl
identifi
whether
one
expos
dosag
rapidli
bodi
elimin
toxic
well
possibl
identifi
short
long
term
effect
final
recent
studi
patel
colleagu
provid
evid
exposom
inde
measur
characteris
studi
conduct
environmentalwid
associ
studi
ewa
type
diabet
mellitu
epidemiolog
data
comprehens
interpret
manner
similar
gwa
associ
found
environment
factor
includ
organochlorin
pesticid
nutrientsvitamin
polychlorin
biphenyl
dioxin
studi
shown
potenti
crossreact
antigen
within
pancreat
islet
cell
cow
milk
casein
sibl
type
diabet
multipl
sclerosi
myelin
oligodendrocyt
glycoprotein
milk
butyrophilin
highlight
potenti
role
food
antigen
trigger
autoimmun
diseas
similar
approach
use
futur
studi
role
exposom
develop
autoimmun
diseas
especi
develop
genet
suscept
individu
sever
year
decad
follow
initi
insult
one
major
obstacl
complet
analysi
trigger
heterogen
unlik
cover
compon
homogen
technolog
platform
human
biomark
measur
subject
interand
intrasubject
varianc
includ
composit
receiv
data
one
model
appear
sisyphean
task
even
age
ultrafast
comput
therefor
breakdown
multivers
compon
easier
access
homogen
realm
marker
seem
reason
next
step
techniqu
utilis
detect
infecti
agent
like
multiparametr
immunoassay
antibodi
variou
isotyp
specif
bacteri
viral
antigen
urin
stool
cultur
polymeras
chain
reaction
pcr
consid
robust
integrat
routin
screen
detect
presenc
infecti
caus
agent
use
clinic
small
scale
individu
microbi
agent
everyday
basi
infecti
noninfecti
environment
agent
long
consid
import
develop
autoimmun
list
noninfecti
environment
factor
trigger
autoimmun
vast
includ
tobacco
smoke
pharmaceut
oestrogen
ultraviolet
radiat
silica
solvent
dietari
compon
heavi
metal
dental
materi
vaccin
collagen
silicon
implant
tabl
infecti
trigger
implic
autoimmun
also
numer
includ
bacteria
virus
parasit
fungi
infect
burden
correspond
geoepidemiolog
serolog
evid
cooccurr
antiinfecti
agent
observ
interest
infect
burden
may
differ
one
autoimmun
diseas
anoth
analog
autoantibodi
burden
nonautoimmun
individu
infect
variou
agent
point
toward
close
relat
exposur
sever
infecti
agent
develop
autoantibodi
reactiv
point
view
help
defin
subgroup
trigger
infectom
part
exposom
refer
collect
individu
infecti
exposur
associ
diseas
case
specif
autoimmun
diseas
may
also
demonstr
alter
diseas
state
affect
alter
flora
within
microbiom
exampl
includ
trace
infecti
trigger
autoimmun
infectom
z
infecti
agent
particip
seri
event
critic
initi
autoimmun
develop
autoimmun
diseas
trace
variou
time
point
trace
infecti
agent
may
help
us
understand
extent
involv
loss
immunolog
breakdown
andor
mainten
autoreact
immun
respons
lead
self
destruct
infect
time
differ
respons
chain
reaction
event
led
autoimmun
diseas
may
particip
remissionrelaps
clinic
pattern
seen
onset
diseas
treatment
antibiot
exposur
toxic
metal
silicon
xenobiot
exposur
may
well
alter
diseas
cours
progress
alter
flora
within
microbiom
increas
likelihood
infect
diseas
caus
infect
may
also
increas
burden
oxid
stress
hygien
hypothesi
underlin
protect
role
play
infect
clinic
experiment
data
anim
model
implic
infect
develop
autoimmun
autoimmun
diseas
one
beststudi
exampl
infectioninduc
autoimmun
acut
rheumat
fever
present
sever
week
infect
streptococcu
pyogen
well
establish
molecular
mimicri
bacteri
mprotein
human
lysogangliosid
respons
loss
immunolog
toler
develop
autoimmun
genet
suscept
individu
exampl
includ
associ
helicobact
pylori
autoimmun
gastriti
well
trypanosoma
cruzi
chaga
cardiomyopathi
mycoplasma
rheumatoid
arthriti
although
experiment
model
autoimmun
diseas
studi
like
mention
provid
data
support
role
play
singl
infecti
trigger
prevail
idea
multitud
infect
birth
term
infectom
contribut
induct
autoimmun
fact
rolf
zinkernagel
hypothesi
increas
predisposit
autoimmun
diseas
develop
world
may
due
overal
hostinfect
balanc
begin
earli
transfer
matern
antibodi
via
placenta
via
breast
milk
gastrointestin
tract
question
aris
one
identifi
specif
infecti
agent
respons
initi
autoimmun
diseas
studi
anim
provid
clue
resembl
human
set
poor
case
ideal
investig
carri
affect
individu
howev
work
perform
biolog
materi
obtain
patient
given
autoimmun
diseas
difficult
singl
diseasetrigg
microb
undoubtedli
inform
collect
microbi
gene
particular
region
gut
oral
caviti
also
known
microbiom
provid
import
hint
potenti
involv
develop
protect
autoimmun
howev
differenti
pathogen
potenti
nonharm
one
latter
repres
great
major
fact
isol
microb
littl
initi
immunemedi
inflammatori
process
lead
given
diseas
moreov
induct
autoimmun
virus
bacteria
probabl
done
hitandrun
mechan
caus
agent
clear
circul
time
diagnosi
track
individu
exposur
infecti
agent
well
antimicrobi
immun
respons
may
import
establish
caus
link
infect
autoimmun
studi
attempt
investig
role
infectom
induct
remissionrelaps
state
autoimmun
diseas
may
need
focu
autoimmun
diseas
multipl
sclerosi
rheumatoid
arthriti
patient
diseas
experi
frequent
remiss
relaps
well
fluctuat
diseas
activ
poorli
understood
system
lupu
erythematosu
multipl
sclerosi
rheumatoid
arthriti
three
best
studi
diseas
far
specif
viral
agent
consid
import
develop
diseas
breakdown
immunolog
toler
well
exposur
metal
variou
chemic
compon
also
link
two
condit
would
interest
see
exposur
alter
presenc
infecti
agent
may
case
exposur
certain
xenobiot
increas
suscept
diseas
caus
microorgan
possibl
elimin
organ
determin
protect
arguabl
ideal
clinic
set
studi
role
infectom
autoimmun
would
involv
typic
autoimmun
diseas
long
prodrom
stage
serial
test
biolog
materi
individu
progress
asymptomat
subclin
phase
clinic
diseas
would
optim
studi
infectom
exampl
includ
system
lupu
erythematosu
sle
multipl
sclerosi
ms
primari
biliari
cirrhosi
pbc
name
characteris
highli
specif
antibodi
may
appear
year
even
decad
onset
symptom
diseas
also
long
prodrom
stage
cours
highli
vari
among
individu
relaps
remiss
state
seen
reason
remain
unknown
characterist
featur
diseas
report
pathogen
relationship
infecti
agent
make
ideal
candid
studi
infectom
system
lupu
erythematosu
sle
often
characteris
prodrom
stage
antibodi
posit
predominantli
antism
antiro
symptomatolog
recent
studi
also
found
signific
proport
first
degre
rel
sle
patient
posit
sever
autoantibodi
name
ana
mostli
antidsdna
antirossa
mani
specif
fact
ana
titr
antidsdna
antirossa
antichromatin
may
high
predict
valu
sle
diagnosi
reason
underli
develop
andor
progress
clinic
diseas
well
mechan
underli
diseas
flare
remain
elus
howev
sever
infecti
agent
implic
includ
ebv
cytomegaloviru
cmv
parvoviru
featur
make
sle
ideal
model
infectom
given
strong
evid
infecti
trigger
addit
unpredict
clinic
cours
ebv
appear
associ
sle
variat
suscept
base
demograph
genet
characterist
harley
colleagu
propos
progress
ebv
infect
follow
epsteinbarr
viru
nuclear
antigen
antibodi
product
predispos
develop
crossreact
autoantibodi
progress
clinic
sle
harley
jame
indic
first
lupu
specif
antibodi
direct
interestingli
also
bind
lupu
specif
antigen
sm
ro
mani
implic
virus
exact
mechan
induc
autoimmun
yet
clear
howev
one
group
indic
molecular
mimicri
mechan
regard
ebv
sle
note
similar
ebv
peptid
pppgrrp
pppgmrpp
peptid
sm
group
test
ana
posit
adult
sle
patient
two
age
race
sex
match
control
per
patient
evid
previou
infect
ebv
cmv
herp
simplex
varicella
zoster
viru
vzv
elisa
among
sle
patient
previou
ebv
infect
compar
control
differ
found
regard
rate
infect
virus
studi
wang
et
al
found
ebvencod
latent
membran
protein
induc
heighten
sensit
tolllik
receptor
tlr
ligand
stimul
increas
prolifer
antism
bcell
andor
increas
antibodi
secret
cell
differenti
parvoviru
also
found
associ
sle
although
evid
clear
cut
ebv
group
bengtsson
test
sle
patient
age
sex
match
control
parvoviru
igg
antibodi
evid
parvoviru
found
sle
compar
control
one
analysi
control
higher
posit
sle
group
symptom
sle
parvoviru
infect
may
similar
prospect
studi
involv
patient
acut
parvoviru
infect
attempt
determin
whether
symptom
persist
whether
infect
contribut
develop
sle
clinic
laboratori
investig
perform
month
initi
infect
arthralgia
persist
month
three
femal
patient
greater
two
year
one
femal
resolv
remain
case
within
week
one
femal
persist
arthralgia
two
year
ana
posit
hypercomplementaemia
fulfil
diagnost
criteria
sle
ra
despit
lack
evid
link
parvoviru
induct
sle
one
case
report
year
old
femal
sle
diseas
flareup
follow
parvoviru
infect
suggest
parvoviru
caus
diseas
flare
sle
patient
parvoviru
evid
link
cmv
sle
scarc
hrycek
colleagu
found
femal
sle
patient
evid
cmv
infect
compar
control
well
anoth
studi
found
cmv
antigen
trigger
humor
immun
sle
patient
autoimmun
prone
mice
lack
evid
link
particular
virus
sle
infer
noninvolv
reflect
difficulti
detect
infecti
organ
may
transient
patient
like
diagnosi
sle
andor
sle
flare
occur
infect
infectom
serv
model
case
atrisk
patient
first
degre
rel
sle
patient
found
posit
autoantibodi
may
screen
regular
interv
likewis
sle
patient
may
screen
chang
clinic
cours
flare
may
correl
infect
sever
diseas
well
defin
connect
h
pyloriinduc
idiopath
thrombocytopen
purpura
could
explor
method
use
indic
also
provid
narroweddown
list
organ
evalu
regard
mechan
induc
autoimmun
multipl
sclerosi
ms
serv
anoth
exampl
infectom
model
may
appli
ms
chronic
autoimmun
neurolog
syndrom
characteris
chronic
inflamm
demyelin
gliosi
central
nervou
system
cn
characteris
period
relaps
remiss
reason
understood
current
evid
suggest
risk
acquir
ms
spread
long
period
time
limit
childhood
earli
adult
life
preval
form
syndrom
call
relapsingremit
ms
characteris
flare
wherebi
preexist
symptom
becom
sever
new
symptom
develop
flare
follow
phase
complet
partial
recoveri
durat
highli
variabl
among
affect
individu
consider
proport
patient
acquir
progress
disabl
without
diseas
relaps
secondari
progress
ms
anoth
form
ms
characteris
stabl
progress
diseas
worsen
symptomatolog
cours
diseas
form
also
known
primari
progress
ms
ppm
two
form
diseas
also
found
total
contradictori
outcom
benign
form
ms
usual
present
minim
mild
progress
disabl
clinic
characteris
full
recoveri
sporad
sensori
episod
hand
marburg
variant
ms
characteris
rapidli
progress
diseas
lead
accumul
disabl
eventu
death
mechan
respons
develop
clinic
distinct
diseas
phenotyp
poorli
understood
patholog
hallmark
ms
inflammatori
lesion
area
demyelin
cn
compos
mononuclear
cell
infiltr
perivascular
space
develop
plaqu
mononuclear
cell
larg
compos
b
lymphocyt
plasma
cell
macrophag
microglia
posit
stain
igg
found
peripher
region
plaqu
addit
approxim
ms
patient
show
intrathec
igg
synthesi
cerebrospin
fluid
csf
environment
genet
compon
clearli
involv
aetiolog
ms
geograph
twin
data
indic
greater
environment
compon
howev
ident
twin
time
like
develop
ms
cotwin
affect
wherea
nontwin
sibl
time
like
genet
gwa
implic
sever
allel
strongest
associ
seven
gwa
studi
conduct
includ
nearli
ms
patient
control
implic
gene
includ
nonetheless
implic
gene
demonstr
odd
ratio
less
ms
twin
demonstr
concord
indic
environment
influenc
diseas
pathogenesi
noninfecti
infecti
compon
implic
involv
develop
ms
within
group
noninfecti
agent
vitamin
particular
interest
ms
also
sever
autoimmun
diseas
vitamin
appear
play
role
modul
proinflammatori
pathway
cell
regul
increas
distanc
equat
correl
low
vitamin
interestingli
ms
rate
increas
distanc
equat
increas
well
popul
increas
dietari
vitamin
intak
lower
rate
ms
australian
studi
found
decreas
risk
first
demyelin
event
increas
sun
exposur
also
increas
level
serum
vitamin
also
found
studi
well
effect
month
birth
ms
develop
appar
famili
ms
group
suggest
influenc
prenat
vitamin
level
well
interact
gene
environ
like
mani
condit
smoke
also
associ
ms
develop
recent
metaanalysi
overwhelmingli
associ
smoke
ms
geneenviron
interact
suggest
regard
smoke
presenc
absenc
hlaa
smoker
genet
combin
appear
increas
risk
develop
ms
whether
due
effect
nitrosamin
heavi
metal
cigarett
smoke
clear
limit
evid
role
heavi
metal
patient
ms
infecti
agent
investig
regard
ms
includ
bacteria
virus
tabl
implic
virus
includ
ebv
human
herp
viru
relapseremitt
pattern
human
herp
viru
similar
clinic
pattern
ms
reservoir
found
cn
tissu
addit
csf
serum
ms
patient
molecular
mimicri
indic
sequenc
homolog
found
myelin
basic
protein
encod
crossreact
cell
respond
protein
type
found
elev
ms
patient
varicella
zoster
viru
torqu
teno
viru
retrovirus
coronavirus
jc
viru
also
implic
limit
evid
reactiv
sever
viral
peptid
found
led
specul
continu
exposur
varieti
virus
lead
cell
expans
reactiv
highli
conserv
protein
includ
selfpeptid
infectom
condit
other
may
clarifi
question
regard
aetiolog
may
also
identifi
caus
certain
diseas
characterist
variabl
present
progress
among
pbc
patient
diseas
flare
patient
sle
relapseremitt
among
ms
patient
condit
serv
model
infectom
analysi
pbc
use
model
diseas
investig
role
exposom
inde
infectom
autoimmun
diseas
rare
mani
diseas
b
long
silent
phase
wellestablish
biomark
determin
highrisk
popul
c
present
subgroup
patient
differ
diseas
progress
andor
concomit
autoimmun
diseas
treat
immunosuppess
drug
might
deterior
immunolog
assess
infectom
e
grow
evid
support
genet
environment
infecti
factor
involv
pathogenesi
diseas
recurr
urinari
tract
infect
uti
cigarett
smoke
oestrogen
defici
plethora
experiment
clinic
data
clearli
indic
diseas
inde
autoimmun
natur
infecti
agent
xenobiot
mimick
modifi
core
epitop
region
major
autoantigen
pbc
appear
induc
immunemedi
destruct
bile
duct
pbc
affect
liver
access
affect
organ
research
purpos
possibl
time
diagnosi
via
liver
biopsi
cours
diseas
earli
advanc
stage
possibl
diseas
diabet
mellitu
type
line
alreadi
discuss
ideal
situat
long
prodrom
period
pbc
long
preclin
phase
characteris
asymptomat
period
evid
autoimmun
marker
form
autoantibodi
follow
biochem
evid
liver
damag
final
clinicallyevid
diseas
progress
asymptomat
symptomat
pbc
may
take
year
decad
virtual
patient
pbc
hightitr
antimitochondri
antibodi
ama
time
diagnosi
also
presenc
ama
predict
eventu
diseas
develop
pbc
patient
diseasespecif
antinuclear
autoantibodi
ana
appear
advanc
diseas
poorer
prognosi
individu
highest
risk
develop
pbc
famili
member
pbc
patient
vast
major
patient
pbc
experi
concomit
autoimmun
diseas
sicca
syndrom
autoimmun
thyroid
rheumatoid
arthriti
autoimmun
hepat
system
sclerosi
reason
behind
fast
pace
progress
seen
patient
pbc
unknown
attempt
predefin
individu
progress
faster
other
larg
unsuccess
pbc
appear
respond
immunosuppress
treatment
make
diseas
perfect
studi
involv
infecti
agent
cours
diseas
without
need
consid
effect
immunosuppress
therapi
relapseremiss
state
pbc
patient
instead
treat
ursodeoxychol
acid
udca
adequ
dose
mgkgday
clear
whether
udca
immunomodulatori
properti
number
environment
factor
implic
pbc
bottomup
approach
variou
epidemiolog
studi
examin
associ
risk
factor
includ
numer
xenobiot
infecti
agent
anim
model
support
notion
genet
pbc
appear
includ
hla
nonhla
sexlink
saccharomyc
cerevisia
gene
particular
allel
associ
may
indirectli
relev
pathogenesi
diseas
may
influenc
penetr
infecti
agent
exampl
neg
associ
pbc
protect
sever
virus
affect
liver
hepat
b
c
lack
hla
allel
protect
pbc
associ
resist
specif
pathogen
may
lead
suscept
infect
respons
induct
diseas
find
underlin
urgent
need
investig
infectom
parallel
gwa
infect
burden
involv
ebv
cmv
toxoplasma
recent
report
patient
pbc
howev
list
pathogen
involv
pbc
vast
escherichia
coli
rel
strong
evid
base
tabl
molecular
mimicri
consid
like
mechan
could
account
initi
liver
autoimmun
diseas
includ
pbc
much
exposom
reflect
collat
exposur
infectom
may
reflect
bacteri
viral
parasit
exposur
may
contribut
develop
autoimmun
diseas
studi
infectom
need
customis
take
account
diseas
investig
type
sampl
collect
larg
depend
diseas
investig
gener
stepwis
approach
infectom
analysi
present
would
follow
investig
ideal
could
perform
birth
baselin
individualpati
present
first
time
clinic
inform
import
order
subgroup
individu
high
low
risk
collect
urin
oronas
swab
saliva
faecal
materi
blood
isol
plasma
serum
peripher
blood
mononuclear
cell
pbmc
regular
followup
yearli
collect
sampl
meticul
record
clinic
data
collect
sampl
need
antiinfect
treatment
appli
incidentalcasu
infect
preclin
stage
diseas
may
affect
final
outcom
underli
process
store
sampl
patient
laboratori
andor
clinic
featur
relat
diseas
analysi
collect
sampl
infecti
agent
known
associ
diseas
box
analysi
use
multiplex
technolog
infecti
agent
see
section
screen
analysi
provid
inform
regard
infect
burden
varioustim
point
associ
analys
provid
evid
knownunknown
infecti
agent
develop
symptomat
diseas
continu
analysi
cours
diseas
may
reveal
close
link
specif
agent
clinic
phenotyp
diseas
studi
role
infecti
agent
develop
autoimmun
diseas
whether
ra
sle
ms
pbc
may
reveal
agent
involv
develop
diseas
well
concomit
autoimmun
diseas
like
combin
particular
gene
particular
infecti
exposur
respons
develop
autoimmun
diseas
without
particular
concomit
autoimmun
diseas
word
may
sever
infectom
sle
defin
sle
particular
concomit
autoimmun
diseas
cours
appli
autoimmun
diseas
recent
describ
microbiom
concept
separ
infectom
microbiom
defin
collect
microbi
gene
particular
region
gut
inguin
creas
oral
caviti
virtual
bodi
site
microbiom
may
reflect
normal
patholog
profil
organ
exampl
microbiom
gut
analys
healthi
individu
identifi
three
distinct
profil
cluster
known
enterotyp
similar
studi
perform
oral
caviti
well
microbiom
may
also
appli
diseaseaffect
bodi
site
gastrointestin
tract
children
irrit
bowel
syndrom
ib
studi
saulnier
colleagu
obtain
faecal
sampl
children
ib
healthi
children
age
year
sampl
analys
rrna
gene
sequenc
show
elev
percentag
gut
flora
children
ib
haemophilu
parainfluenza
promin
compon
infectom
differ
first
infectom
relat
infecti
organ
associ
diseas
question
oppos
total
organ
patholog
nonpatholog
within
human
microbiom
second
infectom
reflect
site
infect
oppos
one
bodi
site
usual
repres
microbiom
well
microbiom
studi
date
larg
concentr
bacteri
speci
wherea
infectom
take
account
patholog
bacteria
virus
parasit
fungi
infectom
limit
affect
site
organ
includ
biolog
fluid
well
sampl
variou
bodysit
includ
oral
caviti
argu
organ
human
microbiom
usual
induc
antigen
specif
system
humor
cellular
immun
respons
provok
local
system
inflammatori
respons
other
believ
organ
may
directli
pathogen
creat
dysbiosi
gut
flora
particip
induct
autoimmun
key
differ
microbiom
infectom
former
appreci
direct
indirect
effect
immun
respons
infecti
agent
pivot
initi
autoaggress
immunemedi
selftarget
patholog
infectom
monitor
microbialhost
immun
import
isol
potenti
harm
bacteri
product
sinc
host
microb
immunolog
interact
like
caus
selfdestruct
case
noncytopath
virus
microb
although
infectom
microbiom
distinct
entiti
may
use
symbiot
provid
micropatholog
profil
profil
particular
diseas
well
microbiom
essenti
defin
normal
actual
recent
microbiom
studi
abl
provid
idea
normal
may
gut
perform
metagenom
screen
bacteri
popul
region
exampl
case
pbc
may
pertin
understand
normal
microbiom
urinari
bladder
vagina
infect
site
associ
pbc
bodi
site
may
also
need
investig
inhal
consumpt
potenti
pathogen
organ
also
implic
associ
organ
locat
potenti
bodysit
would
compris
infectom
establish
normal
well
infecti
may
contribut
understand
network
event
exposur
lead
diseas
develop
possibl
seri
exposur
lead
increas
suscept
exposur
could
defin
infectom
model
unlik
gwa
microbiom
unlik
popul
screen
infectom
compon
could
perform
due
lack
integr
analysi
platform
may
reason
screen
particular
group
individu
risk
develop
autoimmun
diseas
like
famili
member
individu
hla
profil
confer
risk
given
diseas
monitor
may
reveal
whether
addit
infect
play
role
progress
diseas
symptomat
stage
addit
particular
exposomeinfectom
profil
may
found
among
patient
rapidli
progress
diseas
subset
pbc
patient
relaps
remitt
state
ms
flare
sle
approach
may
delin
infecti
agent
respons
diseas
develop
andor
progress
well
identifi
associ
rapid
versu
slow
progress
remitt
flare
establish
infectom
would
reli
detect
microbiolog
materi
patient
favour
easetosampl
materi
like
blood
urin
saliva
sever
method
may
done
alreadi
use
research
purpos
serolog
detect
igm
iga
igg
antibodi
respons
microb
virus
fungi
like
common
fastest
cost
effect
method
independ
actual
presenc
respect
infecti
agent
monitor
seroconvers
antibodi
respons
isotyp
class
switch
igm
igg
imper
identif
newli
acquir
infecti
trigger
time
end
part
immunom
relat
infect
integr
part
infectom
primari
goal
identifi
microbi
trigger
autoimmun
immunoassay
determin
antibodi
eg
elisa
broadli
avail
high
degre
robust
standardis
compar
cheap
furthermor
diagnost
scenario
multiparametr
immunoassay
eg
lineblot
detect
antibodi
tickborn
diseas
exist
facilit
determin
antibodi
sever
even
multipl
entiti
time
limit
amount
sampl
highest
complex
uptod
reach
use
protein
microarray
allow
screen
sever
thousand
antibodi
entiti
time
howev
platform
far
use
screen
immun
profil
individu
small
number
similar
infecti
agent
commerci
solut
similar
degre
standardis
contain
human
protein
avail
major
breakthrough
might
result
develop
highdens
peptidom
librari
relev
microb
virus
similar
concept
peptidom
librari
cover
human
protein
eg
librari
human
peptidom
larg
german
studi
use
pcr
approach
detect
varieti
organ
archiv
liver
tissu
pbc
patient
approach
also
adopt
sever
studi
examin
role
mycobacteria
pbc
well
anoth
group
use
method
detect
betaretrovir
materi
liver
lymph
node
tissu
pbc
patient
similar
studi
conduct
autoimmun
diseas
multiparametr
detect
viral
bacteri
genet
materi
tissu
may
anoth
promis
approach
recent
year
dna
sequenc
technolog
undergon
outstand
upgrad
socal
highthroughput
dna
sequenc
determin
hundr
megabas
dna
sequenc
per
run
enabl
analysi
broad
rang
infecti
agent
massiv
parallel
sequenc
might
next
step
approach
sensit
procedur
avail
allow
detect
multitud
infecti
agent
time
howev
consider
cost
test
limit
wide
use
immunohistochemistri
detect
sever
microbi
agent
tissu
sampl
appli
though
like
tissu
base
method
ideal
establish
infectom
time
consum
tissu
affect
organ
may
readili
avail
patient
analysi
blood
faecal
materi
urin
saliva
plausibl
use
screen
reflect
topdown
approach
suggest
research
mention
multiplex
pcr
use
tool
evalu
presenc
microorgan
varieti
sampl
type
microbiom
studi
also
highlight
use
rrna
gene
sequenc
allow
massanalysi
sampl
howev
one
drawback
approach
comparison
immun
profil
risk
miss
right
time
site
sampl
screen
question
also
remain
bodi
site
sampl
addit
affect
organ
gener
system
infect
indic
sampl
may
includ
urin
stool
sampl
urinari
gastrointestin
tract
infect
respect
blood
cultur
febril
patient
addit
clinic
overt
infect
mani
patient
autoimmun
may
latent
infect
lyme
diseas
mycoplasma
exampl
includ
hidden
chronic
low
grade
infect
associ
dental
treatment
fact
oral
caviti
commonli
examin
infect
patient
autoimmun
diseas
would
like
use
examin
sampl
oral
caviti
overt
infect
accumul
evid
indic
oral
hygien
practic
may
induc
alter
flora
oral
mucosa
lead
dysbiosi
gut
microbiom
therebi
contribut
pathogenesi
ibd
hand
increas
frequenc
dental
problem
ibd
patient
may
due
alter
oral
flora
complement
find
studi
group
heleniu
indic
patient
rheumat
condit
variou
alter
salivari
flow
composit
oral
health
remain
seen
whether
increas
incid
bacteri
infect
common
among
autoimmun
diseas
oral
microorgan
common
among
condit
propos
model
screen
use
characteris
compon
lead
autoimmun
diseas
develop
progress
may
also
provid
evid
prevent
measur
exampl
demonstr
progress
autoimmun
diseas
depend
upon
infecti
trigger
proper
use
antibiot
even
antivir
therapi
may
initi
earli
manag
patient
antibiot
treatment
infecti
agent
associ
autoimmun
diseas
may
slow
progress
diseas
individu
possibl
prevent
develop
diseas
individu
found
risk
exposur
particular
microb
proven
critic
particular
autoimmun
diseas
develop
measur
may
taken
reduc
exposur
microb
regardless
whether
exogen
endogen
treatment
incorpor
routin
manag
diseas
consensu
statement
authorit
posit
papersguidelin
otherwis
potenti
danger
wellb
patient
genet
environment
compon
involv
pathogenesi
diseas
gwa
contribut
greatli
understand
genet
basi
diseas
theori
exposom
complement
gwa
evolv
complex
exposom
may
requir
broken
sever
subcompon
infectom
reflect
characteris
measur
infecti
organ
expos
relationship
exposomeinfectom
develop
diseas
individu
particular
genet
characterist
may
also
help
us
characteris
diseas
initi
progress
given
grow
knowledg
genet
basi
diseas
may
one
day
possibl
screen
newborn
hla
genet
characterist
infer
suscept
autoimmun
diseas
may
done
routin
current
newborn
screen
infant
particular
suscept
profil
monitor
close
exposur
environment
trigger
may
contribut
develop
particular
autoimmun
diseas
therefor
essenti
establish
genet
basi
diseas
via
gwa
also
environment
compon
diseas
must
establish
exposom
model
coval
bind
xenobiot
genom
dna
extens
explor
revisit
context
light
recent
find
clear
delin
organ
inorgan
materi
establish
infectom
repres
infecti
compon
compris
potenti
infect
initi
diseas
alter
diseas
cours
import
subgroup
exposom
consid
togeth
alongsid
detail
investig
compon
part
like
method
use
establish
analys
infectom
simpl
modif
technolog
alreadi
use
remain
seen
approach
may
appli
potenti
subgroup
exposom
xenobiot
infectioushost
immunolog
interact
autoimmun
poorli
understood
direct
link
infect
autoimmun
difficult
obtain
infectom
refer
collect
individu
exposur
infecti
agent
infectom
characteris
approach
employ
immunom
microbiom
project
studi
infectom
help
us
delin
trigger
autoimmun
